A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 230 shares of ABBV stock, worth $40,383. This represents 0.01% of its overall portfolio holdings.

Number of Shares
230
Previous 247 6.88%
Holding current value
$40,383
Previous $42,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $2,785 - $3,388
-17 Reduced 6.88%
230 $45,000
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $33,744 - $39,405
218 Added 751.72%
247 $42,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $4,634 - $5,280
29 New
29 $5,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pacific Capital Wealth Advisors, Inc Portfolio

Follow Pacific Capital Wealth Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Capital Wealth Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Capital Wealth Advisors, Inc with notifications on news.